Epiminder Limited (FRA:1L7)

Germany · Delayed Price · Currency is EUR

0.1580

-0.0030 (-1.86%)

Last updated: Oct 23, 2026, 8:04 AM CEST

Market Cap	34.70M
Revenue (ttm)	1.29M +379.1%
Net Income	-25.88M
EPS	-0.18
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	700
Open	0.1580
Previous Close	0.1610
Day's Range	0.1580 - 0.1580
52-Week Range	0.1370 - 0.6633
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 24, 2026

About Epiminder

Epiminder Limited engages in the development and manufacture of monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. The company offers Minder system, an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. Its Minder system comprises Minder Implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder Wearable, which receives and stores EEG recordings wirelessly transmitted from the... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2017

Country Australia

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 1L7

Financial Performance

In fiscal year 2026, Epiminder's revenue was 2.13 million, an increase of 379.10% compared to the previous year's 445,000. Losses were -42.73 million, 34.5% more than in 2025.

Financial numbers in AUD Financial Statements